Filing Details
- Accession Number:
- 0001171843-21-002446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-13 11:33:42
- Reporting Period:
- 2021-04-12
- Accepted Time:
- 2021-04-13 11:33:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1684144 | Zomedica Corp. | ZOM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721793 | Stephanie Morley | C/O Zomedica Corp. 100 Phoenix Drive, Suite 125 Ann Arbor MI 48108 | President & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Acquisiton | 2021-04-12 | 305,000 | $0.19 | 1,764,580 | No | 4 | M | Direct | |
| Common Stock, Without Par Value | Disposition | 2021-04-12 | 305,000 | $1.16 | 1,459,580 | No | 4 | S | Direct | |
| Common Stock, Without Par Value | Acquisiton | 2021-04-12 | 500,000 | $0.43 | 1,959,580 | No | 4 | M | Direct | |
| Common Stock, Without Par Value | Disposition | 2021-04-12 | 500,000 | $1.16 | 1,459,580 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-04-12 | 305,000 | $0.00 | 305,000 | $0.19 |
| Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-04-12 | 500,000 | $0.00 | 500,000 | $0.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 445,000 | 2025-03-14 | No | 4 | M | Direct | |
| 0 | 2019-09-16 | 2021-09-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Without Par Value | 1,000 | Indirect | By daughter |
| Common Stock, Without Par Value | 1,000 | Indirect | By daughter |
| Common Stock, Without Par Value | 1,000 | Indirect | By step-daughter |
| Common Stock, Without Par Value | 1,000 | Indirect | By step-son |
| Common Stock, Without Par Value | 1,000 | Indirect | By step-son |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021.
- The option vests in 4 equal annual installments commencing March 13, 2020.
Billionaire Hedge Funds
